Skip to content

Development and Preliminary Application of a Low-Intensity Resistance Training Program Combined with Blood Flow Restriction for Advanced Lung Cancer Patients.

Development and Preliminary Application of a Low-Intensity Resistance Training Program Combined with Blood Flow Restriction for Advanced Lung Cancer Patients.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105924
Enrollment
Unknown
Registered
2025-07-14
Start date
2025-07-15
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Lung Cancer

Interventions

Blood Flow Restriction Exercise Group:Low-Intensity Resistance Training Combined with Blood Flow Restriction.
Control group:None

Sponsors

Sichuan Clinical ResearchCenter for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged >=18 years, with a pathological diagnosis of primary stage IIIb and IV non-small cell lung cancer (NSCLC) or extensive-stage small cell lung cancer (SCLC); 2. Patients without severe cardiovascular and cerebrovascular diseases, without muscle strength or bone and joint abnormalities, and capable of performing low-intensity exercise; 3. Conscious patients, able to communicate without barriers, understand their condition, and voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: 1. Severe cardiopulmonary insufficiency or other major comorbidities that are not suitable for exercise; 2. Patients unable to independently complete rehabilitation training; 3. Patients who have received other exercise rehabilitation interventions or surgical interventions within the last 3 months; estimated survival time 120 bpm, blood pressure >180/100 mmHg, unstable angina, musculoskeletal problems, etc.

Design outcomes

Primary

MeasureTime frame
Muscle Strength;Human body composition;

Secondary

MeasureTime frame
safety;

Countries

China

Contacts

Public ContactTang Xiaoli

Sichuan Clinical ResearchCenter for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu,

1585470513@qq.com+86 189 0817 8871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026